Outcome evaluation in glioblastoma patients using different ranking scores: KPS, GOS, mRS and MRC.
about
Retrospective analysis of bevacizumab in combination with fotemustine in chinese patients with recurrent glioblastoma multiforme.Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma.Surgical resection of malignant gliomas-role in optimizing patient outcome.Endovascular versus Non-Interventional Therapy for Cervicocranial Artery Dissection in East Asian and Non-East Asian Patients: a Systematic Review and Meta-analysisClinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitationsHyperglycemia is independently associated with post-operative function loss in patients with primary eloquent glioblastoma.Radiotherapy with or without temozolomide in elderly patients aged ≥ 70 years with glioblastoma.Infarct volume after glioblastoma surgery as an independent prognostic factor.The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme.DCE-MRI prediction of survival time for patients with glioblastoma multiforme: using an adaptive neuro-fuzzy-based model and nested model selection technique.The Added Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Histogram Analysis in Patients with Glioblastoma: Analysis of Overall and Progression-Free Survival.Prognostic Value of Tumor Volume in Glioblastoma Patients: Size Also Matters for Patients with Incomplete Resection.Female sex, good performance status, and bevacizumab-induced hypertension associated with survival benefit in Asian patients with recurrent glioblastoma treated with bevacizumab.Evolution of the Karnosky Performance Status throughout life in glioblastoma patients.Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group.Retrospective Analysis of Radiological Recurrence Patterns in Glioblastoma, Their Prognostic Value And Association to Postoperative Infarct Volume.
P2860
Q33421314-C7305B03-ADF9-4634-9CFB-7AEBDEACE876Q34234748-A88113DB-6074-46E7-A260-57C2DF94E435Q34324963-73FDE029-A8A4-4D87-AAA9-48429F71E6B3Q35626602-BDF92114-5FEC-4281-A44B-6A9584C9F1F5Q36698177-63C777E7-2BBB-4CFB-8221-00E2FF8E4AB3Q36877051-E140F43C-3560-417C-9D8A-26F79B802021Q37237358-904CB2DC-9FD2-4D1E-B372-40BD53F2BE1EQ37641715-A2B60139-FEC9-4A54-A69D-4E67D9E7759AQ38262684-35E036E9-B714-454A-BAE6-72BF14B50490Q38764240-B49DE98B-289B-4A57-BEE1-49D58A606C19Q41416115-3FC7A444-5BC0-47F7-BA28-F61EC3DFAAC1Q47175955-CA9AAF84-EB47-4075-B59B-F07CCE2074AEQ47672218-93081A53-F1C2-4EDE-9726-FB9A569B3AB0Q48048661-D8FA6BAE-DAF8-475E-8676-4C219ABA9310Q48279219-614A7D40-1583-462B-8E7C-95CD00D230E5Q52655328-DBBBF30C-130F-4579-9040-ECB93533488D
P2860
Outcome evaluation in glioblastoma patients using different ranking scores: KPS, GOS, mRS and MRC.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Outcome evaluation in glioblas ...... scores: KPS, GOS, mRS and MRC.
@en
Outcome evaluation in glioblas ...... scores: KPS, GOS, mRS and MRC.
@nl
type
label
Outcome evaluation in glioblas ...... scores: KPS, GOS, mRS and MRC.
@en
Outcome evaluation in glioblas ...... scores: KPS, GOS, mRS and MRC.
@nl
prefLabel
Outcome evaluation in glioblas ...... scores: KPS, GOS, mRS and MRC.
@en
Outcome evaluation in glioblas ...... scores: KPS, GOS, mRS and MRC.
@nl
P2093
P1476
Outcome evaluation in glioblas ...... scores: KPS, GOS, mRS and MRC.
@en
P2093
P2860
P356
10.1111/J.1365-2354.2008.00956.X
P407
P577
2009-11-11T00:00:00Z